AK5 Antibody

Code CSB-PA897315LA01HU
Size US$166
Order now
Image
  • Western Blot
    Positive WB detected in: Mouse liver tissue, Mouse kidney tissue, Mouse brain tissue
    All lanes: AK5 antibody at 2.5μg/ml
    Secondary
    Goat polyclonal to rabbit IgG at 1/50000 dilution
    Predicted band size: 64, 22, 61 kDa
    Observed band size: 64 kDa

  • Immunohistochemistry of paraffin-embedded human brain tissue using CSB-PA897315LA01HU at dilution of 1:100

  • Immunofluorescent analysis of HepG2 cells using CSB-PA897315LA01HU at dilution of 1:100 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)

The Latest Promotion Free Antibody trial simple
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) AK5 Polyclonal antibody
Uniprot No.
Target Names
AK5
Alternative Names
Adenylate kinase 5 antibody; Adenylate kinase 6 antibody; Adenylate kinase isoenzyme 5 antibody; AK 5 antibody; AK5 antibody; AK6 antibody; ATP AMP transphosphorylase 5 antibody; ATP-AMP transphosphorylase 5 antibody; KAD5 antibody; KAD5_HUMAN antibody; MGC33326 antibody
Raised in
Rabbit
Species Reactivity
Human, Mouse
Immunogen
Recombinant Human Adenylate kinase isoenzyme 5 protein (61-215AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated

The AK5 Antibody (Product code: CSB-PA897315LA01HU) is Non-conjugated. For AK5 Antibody with conjugates, please check the following table.

Available Conjugates
Conjugate Product Code Product Name Application
HRP CSB-PA897315LB01HU AK5 Antibody, HRP conjugated ELISA
FITC CSB-PA897315LC01HU AK5 Antibody, FITC conjugated
Biotin CSB-PA897315LD01HU AK5 Antibody, Biotin conjugated ELISA
Clonality
Polyclonal
Isotype
IgG
Purification Method
>95%, Protein G purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Form
Liquid
Tested Applications
ELISA, WB, IHC, IF
Recommended Dilution
Application Recommended Dilution
WB 1:500-1:5000
IHC 1:20-1:200
IF 1:50-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Nucleoside monophosphate (NMP) kinase that catalyzes the reversible transfer of the terminal phosphate group between nucleoside triphosphates and monophosphates. Active on AMP and dAMP with ATP as a donor. When GTP is used as phosphate donor, the enzyme phosphorylates AMP, CMP, and to a small extent dCMP. Also displays broad nucleoside diphosphate kinase activity.
Gene References into Functions
  1. Results indicate that AK5 expression significantly decreased in temporal lobe epilepsy: the expression of AK5 in epileptic brain tissue may play important roles in epilepsy, especially refractory epilepsy PMID: 27288770
  2. Data demonstrate that human adenylate kinase 5 has two separate functional domains and that both have enzymatic activity. PMID: 19647735
Subcellular Location
Cytoplasm.
Protein Families
Adenylate kinase family
Tissue Specificity
Brain specific.
Database Links

HGNC: 365

OMIM: 608009

KEGG: hsa:26289

STRING: 9606.ENSP00000346577

UniGene: Hs.559718

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*